Hitting a moving target: Evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteria

Neurosurgical Focus

Volumn 24, Issue 5, 2008, Pages

  Pearson, Blake E ^a   Markert, James M ^a   Fisher, Winfield S ^a   Guthrie, Barton L ^a   Fiveash, John B ^b   Palmer, Cheryl A ^c   Riley, Kristen ^a  

^a University of Alabama at Birmingham   (United States)

^b The University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Gamma knife surgery; Meningioma; Radiation therapy; Radiosurgery; World Health Organization

Indexed keywords

ADJUVANT THERAPY; ALGORITHM; ARTICLE; CANCER INVASION; DISEASE MANAGEMENT; HUMAN; INTERDISCIPLINARY COMMUNICATION; MENINGIOMA; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RADIOSURGERY; REOPERATION; RETROSPECTIVE STUDY; SALVAGE THERAPY; SKULL IRRADIATION; TUMOR RECURRENCE; UTILIZATION REVIEW;

ALGORITHMS; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; DISEASE MANAGEMENT; HUMANS; INTERDISCIPLINARY COMMUNICATION; MENINGEAL NEOPLASMS; MENINGIOMA; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; RADIOSURGERY; RADIOTHERAPY, ADJUVANT; REOPERATION; RETROSPECTIVE STUDIES; SALVAGE THERAPY;

EID: 45549085009     PISSN: None     EISSN: 10920684     Source Type: Journal    
DOI: 10.3171/FOC/2008/24/5/E3     Document Type: Article

References (31)

1. Ayerbe J, Lobato RD, de la Cruz J, Alday R, Rivas JJ, Gómez PA, et al: Risk factors predicting recurrence in patients operated on for intracranial meningioma. A multivariate analysis. Acta Neurochir (Wien) 141:921-932, 1999
2. Bruna J, Brell M, Ferrer I, Gimenez-Bonafe P, Tortosa A: Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma. Neuropathology 27:114-120, 2007
3. Burger PC, Shibata T, Kleihues P: The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology. Am J Surg Pathol 10:611-617, 1986
4. Dawson B, Trapp RG: Basic and Clinical Biostatistics, ed 3. New York: McGraw-Hill, 2001
5. Engenhart-Cabillic R, Farhoud A, Sure U, Heinze S, Henzel M, Mennel HD, et al: Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment. Strahlenther Onkol 182:641, 2006
6. Heinrich B, Hartmann C, Stemmer-Rachamimov AO, Louis DN, MacCollin M: Multiple meningiomas: investigating the molecular basis of sporadic and familial forms. Int J Cancer 103:483-488, 2003
7. Ho DM, Hsu CY, Ting LT, Chiang H: Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma. Cancer 94:1538-1547, 2002
8. Jääkeläinen J, Haltia M, Laasonen E, Wahlström T, Valtonen S: The growth rate of intracranial meningiomas and its relation to histology. An analysis of 43 patients. Surg Neurol 24:165-172, 1985
9. Jääkeläinen J, Haltia M, Servo A: Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol 25:233-242, 1986
10. Kleihues P, Burger PC, Scheithauer BW: Histological Typing of Tumors of the Central Nervous System, ed 2. Berlin: Springer-Verlag, 1993
11. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, et al: The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215-229, 2002
12. Kuratsu J, Kochi M, Ushio, Y: Incidence and clinical features of asymptomatic meningiomas. J Neurosurg 92:766-770, 2000
13. Lamszus K: Meningioma pathology, genetics, and biology. J Neuropathol Exp Neurol 63:275-286, 2004
14. Lanzafame S, Torrisi A, Barbagallo G, Emmanuele C, Alberio N, Albanese V: Correlation between histological grade, MIB-l, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up. Pathol Res Pract 196:483-488, 2000
15. Louis DN, Scheithauer BW, Budka H, von Deimling A, Kepes JJ: Meningiomas, in Kleihues P, Cavenee WK (eds): World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Nervous System. Lyon: IARC Press, 2000, pp 176-184
16. Maier H, Ofner D, Hittmair A, Kitz K, Budka H: Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance. J Neurosurg 77:616-623, 1992
17. Modha A, Gutin PH: Diagnosis and treatment of atypical and anaplastic meningiomas: a review. Neurosurgery 57:538-550, 2005
18. Nakasu S, Hirano A, Shimura T, Llena JF: Incidental meningiomas in autopsy study. Surg Neurol 27:319-322, 1987
19. Palma L, Celli P, Franco C, Cervoni L, Cantore G: Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases. J Neurosurg 86:793-800, 1997
20. Perry A, Gutmann DH, Reifenberger G: Molecular pathogenesis of meningiomas. J Neurooncol 70:183-202, 2004
21. Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM: Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol 21:1455-1465, 1997
22. Riemenschneider MJ, Perry A, Reifenberger G: Histological classification and molecular genetics of meningiomas. Lancet Neurol 5:1045-1054, 2006
23. Sankila R, Kallio M, Jääkeläinen J, Hakulinen T: Long-term survival of 1986 patients with intracranial meningioma diagnosed from 1953 to 1984 in Finland. Comparison of the observed and expected survival rates in a population-based series. Cancer 70: 1568-1576, 1992
24. Simon M, Boström JP, Hartmann C: Molecular genetics of meningiomas: from basic research to potential clinical applications. Neurosurgery 60:787-798, 2007
25. Simon M, Boström J, Koch P, Schramm J: Interinstitutional variance of postoperative radiotherapy and follow up for meningiomas in Germany: impact of changes of the WHO classification. J Neurol Neurosurg Psychiatry 77:767-773, 2006
26. Simpson D: The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22-39, 1957
27. Smith JS, Lal A, Harmon-Smith M, Bollen AW, McDermott MW: Association between absence of epidermal growth factor receptor immunoreactivity and poor prognosis in patients with atypical meningioma. J Neurosurg 106:1034-1040, 2007
28. Stafford SL, Perry A, Suman VJ, Meyer FB, Scheithauer BW, Lohse CM, et al: Primarily resected meningiomas: outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988. Mayo Clin Proc 73:936-942, 1998
29. Torp SH, Lindboe CF, Granli US, Moen TM, Nordtømme T: Comparative investigation of proliferation markers and their prognostic relevance in human meningiomas. Clin Neuropathol 20:190-195, 2001
30. Whittle IR, Smith C, Navoo P, Collie D: Meningiomas. Lancet 363:1535-1543, 2004
31. Willis J, Smith C, Ironside JW, Erridge S, Whittle IR, Everington D: The accuracy of meningioma grading: a 10-year retrospective audit. Neuropathol Appl Neurobiol 31:141-149, 2005